Volume 5 Issue 4, Dec 2020

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)

Volume 5 Issue 4, Dec 2020:
Research Highlight
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
Tarek Mohamed Abd El-Aziz,Ahmed Al-Sabi &James D. Stockand